Skip to content
Disclosery

EXANE DERIVATIVES: CVS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on CVS, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 4,597 CVS shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 4,597 shares
    Change vs previous 13F +3,885 shares

    0.24% of the 13F portfolio, value $425,913.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 712 shares
    Change vs previous 13F -363 shares

    0.02% of the 13F portfolio, value $72,061.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 1,075 shares
    Change vs previous 13F +744 shares

    0.03% of the 13F portfolio, value $110,898.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 331 shares
    Change vs previous 13F 0 shares

    0.01% of the 13F portfolio, value $28,089.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 331 shares
    Change vs previous 13F +331 shares

    0.01% of the 13F portfolio, value $27,030.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 0 shares
    Change vs previous 13F -1,511 shares

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  7. period ended2020-12-31
    13F 1,511 shares
    Change vs previous 13F +12 shares

    0.03% of the 13F portfolio, value $103,203.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 1,499 shares
    Change vs previous 13F not available

    0.03% of the 13F portfolio, value $87,542.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).